Your web browser is out of date.

For your security and improved experience online, please update your browser.

This site is intended for healthcare professionals only
×
Share this article
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email
Share on print
Print

How might biofilms affect dressing choice for the diabetic foot?

Chronic wounds, including diabetic foot ulcers, are colonised by micro-organisms. In the person with diabetes – where the immune response is impaired – this poses a major challenge, with control of infection being recognised as an important aspect of wound management.

Biofilms – aggregations of micro-organisms characterised by a protective extracellular matrix – have long represented a significant healthcare issue in areas such as orthopaedic prosthesis and dentistry. It has been estimated that 65% of human infections involve biofilms (Potera, 1999). In recent years, the paradigm of the place of biofilms in chronic wound care has begun to emerge.

Bjarnsholt et al (2008) stated that the reason many chronic ulcers do not heal is due to the presence of biofilms. Biofilms provide bacteria with a complex defence mechanism which allows them to resist the host’s immune system, and antibiotic therapy. James et al (2008) demonstrated the presence of biofilm formation on chronic wounds. They also acknowledged that the role of polymicrobial biofilm communities in preventing wound healing remains unclear.

Challenge of early recognition of biofilms by clinicians
Clinicians may not always equate the presence of a biofilm in the wound bed as being a factor in chronic wound healing. Once a biofilm is established it is difficult to penetrate and disrupt. Therefore, in the authors’ view, early identification is essential to achieve positive outcomes. It is difficult to distinguish a critically colonised wound from a biofilm using clinical indicators, but clues may include the appearance of a slimy film over the wound bed, presence of slough and lack of response to antibiotic therapy or antimicrobial dressings. Greater guidance on early identification of those individuals at risk would be of value.

The role of dressings and wound cleansing
Integral to the management of the diabetic foot is regular debridement of devitalised tissue. This helps reduce the bacterial load and remove senescent cells, thus returning the wound to an acute state. In their study on acute and chronic wound fluid, James et al (2008) did not detect biofilm formation in acute wounds. Could it be postulated that regular debridement may also help to reduce biofilm formation? Greater research is required in this area.

To remove biofilms on surfaces such as teeth, regular brushing with a toothbrush is recommended. While scrubbing a chronic wound is not advocated, other practical methods should be considered! Irrigation of the wound can remove loose debris and chronic wound fluid, but may be inadequate for removing micro-colonies of bacteria. The role of surfactant irrigation systems in wound cleansing may, therefore, be a route to explore, and worthy of further debate.

Antimicrobial dressings such as those containing silver are commonly used in wound care; however, not all antimicrobial dressings perform in the same way. Potemkina et al (2008) suggest that the action of silver may depend on the physiological state of biofilms and the longevity of treatment. The longer the biofilm exists, the greater the population density of bacteria; therefore, the need for early detection and prevention is an important factor in determining care pathways.

Antimicrobial dressings with a rapid speed-of-kill and sustained release to prevent reforming of the biofilm may provide a balance to achieve this.

Is the presence of biofilms a hidden epidemic in the diabetic foot? If so, how do we provide support to clinicians to identify clinical indicators and sound advice as to which dressing to use and why?

Chronic wounds, including diabetic foot ulcers, are colonised by micro-organisms. In the person with diabetes – where the immune response is impaired – this poses a major challenge, with control of infection being recognised as an important aspect of wound management.

Biofilms – aggregations of micro-organisms characterised by a protective extracellular matrix – have long represented a significant healthcare issue in areas such as orthopaedic prosthesis and dentistry. It has been estimated that 65% of human infections involve biofilms (Potera, 1999). In recent years, the paradigm of the place of biofilms in chronic wound care has begun to emerge.

Bjarnsholt et al (2008) stated that the reason many chronic ulcers do not heal is due to the presence of biofilms. Biofilms provide bacteria with a complex defence mechanism which allows them to resist the host’s immune system, and antibiotic therapy. James et al (2008) demonstrated the presence of biofilm formation on chronic wounds. They also acknowledged that the role of polymicrobial biofilm communities in preventing wound healing remains unclear.

Challenge of early recognition of biofilms by clinicians
Clinicians may not always equate the presence of a biofilm in the wound bed as being a factor in chronic wound healing. Once a biofilm is established it is difficult to penetrate and disrupt. Therefore, in the authors’ view, early identification is essential to achieve positive outcomes. It is difficult to distinguish a critically colonised wound from a biofilm using clinical indicators, but clues may include the appearance of a slimy film over the wound bed, presence of slough and lack of response to antibiotic therapy or antimicrobial dressings. Greater guidance on early identification of those individuals at risk would be of value.

The role of dressings and wound cleansing
Integral to the management of the diabetic foot is regular debridement of devitalised tissue. This helps reduce the bacterial load and remove senescent cells, thus returning the wound to an acute state. In their study on acute and chronic wound fluid, James et al (2008) did not detect biofilm formation in acute wounds. Could it be postulated that regular debridement may also help to reduce biofilm formation? Greater research is required in this area.

To remove biofilms on surfaces such as teeth, regular brushing with a toothbrush is recommended. While scrubbing a chronic wound is not advocated, other practical methods should be considered! Irrigation of the wound can remove loose debris and chronic wound fluid, but may be inadequate for removing micro-colonies of bacteria. The role of surfactant irrigation systems in wound cleansing may, therefore, be a route to explore, and worthy of further debate.

Antimicrobial dressings such as those containing silver are commonly used in wound care; however, not all antimicrobial dressings perform in the same way. Potemkina et al (2008) suggest that the action of silver may depend on the physiological state of biofilms and the longevity of treatment. The longer the biofilm exists, the greater the population density of bacteria; therefore, the need for early detection and prevention is an important factor in determining care pathways.

Antimicrobial dressings with a rapid speed-of-kill and sustained release to prevent reforming of the biofilm may provide a balance to achieve this.

Is the presence of biofilms a hidden epidemic in the diabetic foot? If so, how do we provide support to clinicians to identify clinical indicators and sound advice as to which dressing to use and why?

Bjarnsholt T, Kirketerp-Møller K, Jensen PØ et al (2008) Why chronic wounds won’t heal: a novel hypothesis. Wound Repair and Regeneration 16: 2–10
James GA, Swogger E, Wolcott R et al (2008) Biofilms in chronic wounds. Wound Repair and Regeneration 16: 37–44
Potemkina A, Kostenko V, Pang W et al (2008) Silver-Containing Dressings Demonstrate Time-Dependent Bactericidal Effects against Staphylococcal Biofilms. http://www.enme.ucalgary.ca/research/biofilms/image/post_3.gif (accessed: 16/05/08)
Potera C (1999) Forging a link between biofilms and disease. Science 283: 1837–9

Share this article
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp
For the latest news and articles

Sign up to all DiabetesontheNet journals

© Copyright Omniamed Communications. All Rights Reserved​
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom​
Omniamed logo white
For the latest news and articles

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

DiabetesontheNet Logo

This website is for UK healthcare professionals only. To continue, please confirm that you are a UK healthcare professional below.